𝔖 Bobbio Scriptorium

✦ LIBER ✦

Valsartan reduces morbidity in people with heart failure receiving a low dose of ACE inhibitor and no beta-blocker

Book ID: 116415883
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 123 KB
Volume: 9
Category: Article
ISSN: 1361-2611
DOI: 10.1016/j.ebcm.2005.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inpatient Initiation and Target Dosing o

Inpatient Initiation and Target Dosing of ACE Inhibitors and Beta-Blockers in Children with Heart Failure

✍ Jack F. Price; BreAnn N. Taylor; Aamir Jeewa; William J. Dreyer; Susan W. Denfie 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Meta-analyses of mortality and morbidity

Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a β-blocker)

✍ Konstantinos Dimopoulos; Tushar V. Salukhe; Andrew J.S. Coats; Jamil Mayet; Mass 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Review finds combining angiotensin recep

Review finds combining angiotensin receptor blockers with ACE inhibitors in heart failure may only benefit people with contraindications to β blockers: Abstracted from: Dimopoulos K, Salukhe TV, Coats AJ, et al. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol 2004; 93(2–3): 105–11.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB